These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9366278)

  • 21. Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program.
    Kostis WJ; Sargsyan D; Mekkaoui C; Moreyra AE; Cabrera J; Cosgrove NM; Sedjro JE; Kostis JB; Cushman WC; Pantazopoulos JS; Pressel SL; Davis BR
    J Hum Hypertens; 2019 Oct; 33(10):735-740. PubMed ID: 30804464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
    Li JS; Berezny K; Kilaru R; Hazan L; Portman R; Hogg R; Jenkins RD; Kanani P; Cottrill CM; Mattoo TK; Zharkova L; Kozlova L; Weisman I; Deitchman D; Califf RM
    Hypertension; 2004 Sep; 44(3):289-93. PubMed ID: 15262902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [FLAG--a program of achievability of target blood pressure levels during treatment of patients with hypertension with fosinopril].
    Karpov YA;
    Kardiologiia; 2002; 42(1):52-7. PubMed ID: 12494225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET).
    Sowers JR
    Am J Cardiol; 1998 Nov; 82(9B):15R-19R. PubMed ID: 9822138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.
    Alli C; Lombardo M; Zanni D; Agrati AM; Cassani M; Granata S
    Am J Hypertens; 1996 Nov; 9(11):1068-76. PubMed ID: 8931831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fosinopril or sustained-release verapamil on blood pressure and serum catecholamine concentrations in elderly hypertensive men.
    Williams LS; Hill D; Davis J; Lowenthal DT
    Am J Ther; 2000 Jan; 7(1):3-9. PubMed ID: 11319567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
    Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
    Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fosinopril and amlodipine in the treatment of isolated systolic hypertension.
    Pavlović K; Benc D; Kmezić-Grujin J; Stojiljković J; Cemerlić-Adić N; Miljković T; Mesaros P
    Med Pregl; 2004; 57(1-2):45-53. PubMed ID: 15327190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
    Probstfield JL; Applegate WB; Borhani NO; Curb JD; Cutler JA; Davis BR; Furberg CD; Hawkins CM; Lakatos E; Page LB
    Clin Exp Hypertens A; 1989; 11(5-6):973-89. PubMed ID: 2676266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fosinorm in the treatment of essential hypertension with a metabolic syndrome].
    Kobalava ZhD; Kotovskaia IuV; Moryleva ON; Drozdov VN; Ivleva AIa; Moiseev VS
    Ter Arkh; 1997; 69(8):10-3. PubMed ID: 9381382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
    Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
    Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
    Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
    J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial differences are seen in blood pressure response to fosinopril in hypertensive children.
    Menon S; Berezny KY; Kilaru R; Benjamin DK; Kay JD; Hazan L; Portman R; Hogg R; Deitchman D; Califf RM; Li JS
    Am Heart J; 2006 Aug; 152(2):394-9. PubMed ID: 16875928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fosinopril: a new generation of angiotensin-converting enzyme inhibitors.
    Weber MA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S7-12. PubMed ID: 1283429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 38. Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism.
    Stavroulakis GA; Makris TK; Krespi PG; Hatzizacharias AN; Gialeraki AE; Anastasiadis G; Triposkiadis P; Kyriakidis M
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):427-32. PubMed ID: 10999650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.
    Waldemar G; Ibsen H; Strandgaard S; Andersen AR; Rasmussen S; Paulson OB
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):464-70. PubMed ID: 2142429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.